Determining contrast medium dose and rate on basis of lean body weight: Does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT?

Radiology

Volumn 243, Issue 2, 2007, Pages 431-437

  Ho, Lisa M ^a   Nelson, Rendon C ^a   DeLong, David M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IODINE; IOPAMIDOL;

ADIPOSE TISSUE; ADULT; AORTA; ARTICLE; BODY MASS; BODY WEIGHT; CALCULATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTRAST RADIOGRAPHY; DATA ANALYSIS; FEMALE; HUMAN; IMAGE ENHANCEMENT; INFORMED CONSENT; INSTITUTIONAL REVIEW; LEAN BODY WEIGHT; LIVER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIDETECTOR COMPUTED TOMOGRAPHY; PORTAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; STANDARD; TWO TAILED TEST;

ALGORITHMS; ANTHROPOMETRY; BODY WEIGHT; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IOPAMIDOL; MALE; MIDDLE AGED; OBSERVER VARIATION; RADIOGRAPHIC IMAGE ENHANCEMENT; REPRODUCIBILITY OF RESULTS; THINNESS;

EID: 34247533214     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2432060390     Document Type: Article

References (24)

1. Saini S. Multi-detector row CT: principles and practice for abdominal applications. Radiology 2004;233:323-327.
2. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000;174:691-698.
3. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol 2004;183:1673-1689.
4. Yamashita Y, Komohara Y, Uchida M, Hayabuchi N, Shimizu T, Narabayashi I. Abdominal helical CT: evaluation of optimal doses of intravenous contrast, material - a prospective randomized study. Radiology 2000;216: 718-723.
5. Megibow AJ, Jacob G, Heiken JP, et al. Quantitative and qualitative evaluation of volume of low osmolality contrast medium needed for routine helical abdominal CT. AJR Am J Roentgenol 2001;176:583-589.
6. Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics. AJR Am J Roentgenol 1999;172:53-56.
7. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. I. Prediction with a computer model. Radiology 1998;207:647-655.
8. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. II. Effect of reduced cardiac output in a porcine model. Radiology 1998;207:657-662.
9. Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 1995; 195:353-357.
10. Hume R. Prediction of lean body mass from height, and weight. J Clin Pathol 1966;19: 389-391.
11. Hallynck TH, Soep HH, Thomis JA, Boelaert J, Daneels R, Dettli L. Should clearance be normalised to body surface or to lean body mass? Br J Clin Pharmacol 1981;11:523-526.
12. Dorio PJ, Lee FT Jr, Henseler KP, et al. Using a saline chaser to decrease contrast media in abdominal CT. AJR Am J Roentgenol 2003;180:929-934.
13. Haage P, Schmitz-Rode T, Hubner D, Piroth W, Gunther RW. Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax. AJR Am J Roentgenol 2000;174: 1049-1053.
14. Schoellnast H, Tillich M, Deutschmann HA, et al. Improvement of parenchymal and vascular enhancement using saline flush and power injection for multiple-detector-row abdominal CT. Eur Radiol 2004;14:659-664.
15. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-1522.
16. Levene H. Robust tests for the equality of variance. In: Olkin I, ed. Contributions to probability and statistics. Palo Alto, Calif: Stanford University Press, 1960; 278-292.
17. Hanninen EL, Vogl TJ, Felfe R, et al. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. Radiology 2000;216:403-409.
18. Furuta A, Ito K, Fujita T, Koike S, Shimizu A, Matsunaga N. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. AJR Am J Roentgenol 2004;183:157-162.
19. Roos JE, Desbiolles LM, Weishaupt D, et al. Multi-detector row CT: effect of iodine dose reduction on hepatic and vascular enhancement. Rofo 2004;176:556-563.
20. Tsurusaki M, Sugimoto K, Fujii M, Sugimura K. Multi-detector row helical CT of the liver: quantitative assessment of iodine concentration of intravenous contrast material on multiphasic CT - a prospective randomized study. Radiat Med 2004;22:239-245.
21. Awai K, Takada K, Onishi H, Hori S. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multidetector row helical CT. Radiology 2002; 224:757-763.
22. Awai K, Hori S. Effect of contrast, injection protocol with dose tailored to patient weight and fixed injeciton duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 2003;13:2155-2160.
23. Awai K, Hiraishi K, Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 2004;230: 142-150.
24. Ford ES, Mokdad AH, Giles WH, Galuska DA, Serdula MK. Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviors. Obes Res 2005;13: 118-122.